Recent Updates on the Melanin-Concentrating Hormone (MCH) and Its Receptor System: Lessons from MCH1R Antagonists
2010 · Journal of Molecular Neuroscience · 74 citations
https://doi.org/10.1007/s12031-010-9411-4
G
Gregory S. Parks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
982
Citations
14
h-index
19
i10-index
Gregory S. Parks is an academic researcher from Axsome Therapeutics (United States). The author has contributed to research in topics: Sleep and Wakefulness Research & Race, History, and American Society & Sleep and related disorders. The author has an h-index of 14, co-authored 151 publications.
ORCID: 0000-0003-4695-1955Papers by this author
worksAnxiolytic Effects of the MCH1R Antagonist TPI 1361-17
2010 · Journal of Molecular Neuroscience · 17 citations
https://doi.org/10.1007/s12031-010-9425-y
Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario
2022 · Advances in Therapy · 5 citations
https://doi.org/10.1007/s12325-022-02249-4
SURWEY real-world study of solriamfetol: initiation, titration, safety, efficacy, and follow-up experience for patients with obstructive sleep apnea in Germany
2025 · Sleep And Breathing · 2 citations
https://doi.org/10.1007/s11325-025-03275-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat